{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:52:08Z","timestamp":1791287528882,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["17046017"],"award-info":[{"award-number":["17046017"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007416","name":"Japan Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bbagen.2005.11.021","type":"journal-article","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T10:00:24Z","timestamp":1135764024000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis"],"prefix":"10.1016","volume":"1760","author":[{"given":"M.","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.O.S.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jefferis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2005.11.021_bib1","unstructured":"http:\/\/www.us.expasy.org\/sprot\/hpi\/"},{"key":"10.1016\/j.bbagen.2005.11.021_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0167-7799(01)01598-0","article-title":"The human proteomics initiative (HPI)","volume":"19","author":"O'Donovan","year":"2001","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14789450.1.2.207","article-title":"Techniques for studying protein heterogeneity and post-translational modifications","volume":"2","author":"Bauman","year":"2004","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbagen.2005.11.021_bib4","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1021\/jo050278f","article-title":"Protein glycosylation: new challenges and opportunities","volume":"70","author":"Wong","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbagen.2005.11.021_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0304-4165(02)00408-7","article-title":"Human disorders in N-glycosylation and animal models","volume":"1573","author":"Freeze","year":"2002","journal-title":"Biochim. Biophys Acta"},{"key":"10.1016\/j.bbagen.2005.11.021_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/glycob\/cwg079","article-title":"Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis","volume":"13","author":"Butler","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2005.11.021_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2005.11.021_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3140621","article-title":"Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients","volume":"314","author":"Youings","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2005.11.021_bib9","first-page":"2540","article-title":"Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis","volume":"12","author":"Axford","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/bi00378a023","article-title":"Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G","volume":"26","author":"Takahashi","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2005.11.021_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00919332","article-title":"Oligosaccharide structures of immunoglobulin G from two patients with carbohydrate-deficient glycoprotein syndrome","volume":"1","author":"Gu","year":"1994","journal-title":"Glycosyl. Dis."},{"key":"10.1016\/j.bbagen.2005.11.021_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3164\/jcbn.14.61","article-title":"Abnormalities in the oligosaccharide moieties of immunolglobulin G in patients with mytonic dystrophy","volume":"14","author":"Ito","year":"1993","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbagen.2005.11.021_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.2002.01864.x","article-title":"Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis","volume":"129","author":"Holland","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.1004566","article-title":"Activated human PMN synthesize and release a strongly fucosylated glycoform of {alpha}1-acid glycoprotein, which is transiently deposited in human myocardial infarction","volume":"78","author":"Poland","year":"2005","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/bp040016j","article-title":"Glycosylation of recombinant antibody therapeutics","volume":"21","author":"Jefferis","year":"2005","journal-title":"Biotechnol. Prog."},{"issue":"11","key":"10.1016\/j.bbagen.2005.11.021_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tibtech.2005.09.003","article-title":"The production of biopharmaceuticals in plants: Problems, solutions and opportunities","volume":"23","author":"Gomord","year":"2005","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/6179","article-title":"Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity","volume":"17","author":"Umana","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/bit.1119","article-title":"Expression of GTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies of altered glycoforms leads to an increase in ADCC thro\u2032 higher affinity for FcRIII","volume":"74","author":"Davies","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbagen.2005.11.021_bib19","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-Linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.021_bib20","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.021_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2141.1995.tb05352.x","article-title":"The glycosylation of red cell autoantibodies affects their functional activity in vitro","volume":"91","author":"Hadley","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib22","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1046\/j.1432-1327.2000.01528.x","article-title":"Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in chinese hamster ovary cells","volume":"267","author":"Van den Nieuwenhof","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2005.11.021_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/glycob\/10.5.477","article-title":"Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics","volume":"10","author":"Raju","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2005.11.021_bib24","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jps.20319","article-title":"Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins","volume":"94","author":"Sinclair","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2005.11.021_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1387-2656(04)10008-2","article-title":"Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge","volume":"10","author":"Smalling","year":"2004","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.bbagen.2005.11.021_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(00)01557-X","article-title":"Pairing of oligosaccharides in the Fc region of immunoglobulin G","volume":"473","author":"Matsuda","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2005.11.021_bib27","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.4049\/jimmunol.172.9.5489","article-title":"V region carbohydrate and antibody expression","volume":"172","author":"Gala","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0925-4439(93)90067-B","article-title":"Identification of hybrid-type carbohydrate chains on the light chain of human monoclonal antibody specific to lung adenocarcinoma","volume":"1182","author":"Tachibana","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2005.11.021_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/bbrc.1997.5929","article-title":"The variable domain glycosylation in a monoclonal antibody specific to GnRH modulates antigen binding","volume":"234","author":"Khurana","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2005.11.021_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04064.x","article-title":"Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma","volume":"120","author":"Zhu","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib31","unstructured":"http:\/\/www.bioch.ox.ac.uk\/glycob\/posters\/catherine_radcliffe_jenner_2004.pdf"},{"key":"10.1016\/j.bbagen.2005.11.021_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.1998.tb01188.x","article-title":"IgG-Fc mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation","volume":"163","author":"Jefferis","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbagen.2005.11.021_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(02)00019-6","article-title":"Interaction sites on human IgG-Fc for Fc\u03b3R: current models","volume":"82","author":"Jefferis","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbagen.2005.11.021_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbagen.2005.11.021_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj2680529","article-title":"A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins","volume":"268","author":"Jefferis","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2005.11.021_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/abio.1995.1201","article-title":"Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides","volume":"226","author":"Takahash","year":"1995","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.bbagen.2005.11.021_bib37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/glycob\/cwi092","article-title":"Development of structural analysis of sulfated N-glycans by multi-dimensional high performance liquid chromatography mapping methods","volume":"15","author":"Yagi","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2005.11.021_bib38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.molimm.2004.06.003","article-title":"Temperature-dependent isologous Fab\u2013Fab interaction that mediates cryocrystallization of a monoclonal immunoglobulin G","volume":"41","author":"Yagi","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4052\/tigg.15.235","article-title":"GALAXY (Glycoanalysis by the Three Axes of MS and Chromatography): a web application that assists structural analyses of N-glycans","volume":"15","author":"Takahashi","year":"2003","journal-title":"Trends Glycosci. Glycotechnol."},{"issue":"Suppl. 2","key":"10.1016\/j.bbagen.2005.11.021_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/rheumatology\/XXVII.suppl_2.170","article-title":"Decreased B-cell galactosyltransferase activity in rheumatoid arthritis","volume":"27","author":"Axford","year":"1988","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bbagen.2005.11.021_bib41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/art.1780331108","article-title":"Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients","volume":"11","author":"Delves","year":"1990","journal-title":"Arthritis Rheum."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416505003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416505003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:38:50Z","timestamp":1759635530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416505003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0304416505003818"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2005.11.021","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2005.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}